U.S. Department of Health and Human Services
Phillip Gorden

 Contact Info

Tel: 301-402-7340
Email: gordenp@extra.niddk.nih.gov

 Select Experience

  • M.D.Vanderbilt University School of Medicine1961
  • B.A.Vanderbilt University1957

 Related Links


    Phillip Gorden, M.D., Director Emeritus

    Section Chief, Clinical and Cellular Biology SectionDiabetes, Endocrinology, and Obesity Branch
    • Clinical Research


    Patents, materials, and other research resources appear below. Some resources may be available for use through Material Transfer Agreements (MTAs) or licensing agreements.

    Resource Name Description
    Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment (U.S. Patent Application Number 20070099836)

    Leptin, leptin analogs, and leptin derivatives are used to treat patients with lipoatrophy. Leptin is effective against conditions of lipoatrophy for both genetic and acquired forms of the disease. A therapeutically effective amount of leptin can be…

    View Additional Research Resources

    Clinical Trials

    Open studies conducted by NIDDK Principal Investigators appear below that are currently recruiting, not yet recruiting, or available for expanded access.